Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02625961 |
Title | Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Merck Sharp & Dohme Corp. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ITA | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Call for Information (Investigational Site 0023) | Recruiting | Minneapolis | Minnesota | 55455 | United States | Details |
Call for Information (Investigational Site 0002) | Recruiting | Hackensack | New Jersey | 07601 | United States | Details |
Call for Information (Investigational Site 0018) | Recruiting | New Brunswick | New Jersey | 08903 | United States | Details |
Call for Information (Investigational Site 0072) | Recruiting | Cincinnati | Ohio | 45212 | United States | Details |
Call for Information (Investigational Site 0009) | Recruiting | Cleveland | Ohio | 44106 | United States | Details |
Call for Information (Investigational Site 0074) | Recruiting | Bala-Cynwyd | Pennsylvania | 19004 | United States | Details |
Call for Information (Investigational Site 0078) | Recruiting | Myrtle Beach | South Carolina | 29572 | United States | Details |
Merck Sharp & Dohme | Recruiting | North Ryde | Australia | Details | ||
MSD Finland Oy | Recruiting | Espoo | Finland | Details | ||
MSD France | Recruiting | Paris | France | Details | ||
MSD Italia S.r.l. | Recruiting | Rome | Italy | Details | ||
Merck Sharp & Dohme BV | Recruiting | Haarlem | Netherlands | Details | ||
Merck Sharp & Dohme Ilaclari Ltd. Sti | Recruiting | Istanbul | Turkey | Details |